Literature DB >> 27612022

Genetic Analysis of the ZNF512B, SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population.

Faranak Madadi1, Mahmoud Shekari Khaniani2, Ehsan Esmaili Shandiz3, Hormoz Ayromlou4, Safa Najmi4, Babak Emamalizadeh5, Shaghayegh Taghavi5, Javad Jamshidi6, Abbas Tafakhori7, Gholam-Ali Shahidi8, Hossein Darvish5.   

Abstract

AIMS: Parkinson's disease (PD) is one of the most common neurodegenerative disorders; its etiology includes both genetic and environmental factors and their interactions. The ZNF512B, SLC41A1, and ALDH2 genes have recently been identified as contributing to PD. In this study we investigated the association of alleles of these genes with PD in the Iranian population.
METHODS: In a case-control study, rs2275294, rs11240569, and rs4767944, three single nucleotide polymorphisms in ZNF512B, SLC41A1, and ALDH2 genes, respectively, were genotyped in 490 PD patients and 490 controls. The genotype and allele frequencies were compared between the two groups using chi-square and logistic regression tests.
RESULTS: A significant association between the rs11240569 polymorphism and a reduced risk of PD was found (p = 0.014, OR = 0.76, 95% CI: 0.60-0.94 for allele frequencies). We did not find any associations between PD and the rs2275294 and rs4767944 polymorphisms.
CONCLUSION: The association of rs11240569 polymorphism in SLC41A1 gene with reduced risk of PD was replicated in our population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27612022      PMCID: PMC7871989          DOI: 10.1089/gtmb.2016.0133

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  30 in total

1.  SNPassoc: an R package to perform whole genome association studies.

Authors:  Juan R González; Lluís Armengol; Xavier Solé; Elisabet Guinó; Josep M Mercader; Xavier Estivill; Víctor Moreno
Journal:  Bioinformatics       Date:  2007-01-31       Impact factor: 6.937

2.  Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson's disease patients.

Authors:  Yaping Yan; Jun Tian; Xiaoyun Mo; Guohua Zhao; Xinzhen Yin; Jiali Pu; Baorong Zhang
Journal:  Int J Neurosci       Date:  2011-08-04       Impact factor: 2.292

3.  RIT2, a susceptibility gene for Parkinson's disease in Iranian population.

Authors:  Babak Emamalizadeh; Abolfazl Movafagh; Mojdeh Akbari; Somayyeh Kazeminasab; Atena Fazeli; Marzieh Motallebi; Gholam-Ali Shahidi; Peyman Petramfar; Reza Mirfakhraie; Hossein Darvish
Journal:  Neurobiol Aging       Date:  2014-07-19       Impact factor: 4.673

4.  Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.

Authors:  Kiyomitsu Oyanagi; Emiko Kawakami; Kae Kikuchi-Horie; Kazuhiko Ohara; Kentaro Ogata; Sachiko Takahama; Manabu Wada; Tameko Kihira; Masayuki Yasui
Journal:  Neuropathology       Date:  2006-04       Impact factor: 1.906

Review 5.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

6.  SLC41A1 is a novel mammalian Mg2+ carrier.

Authors:  Martin Kolisek; Pierre Launay; Andreas Beck; Gerhard Sponder; Nicolas Serafini; Marcel Brenkus; Elisabeth Maria Froschauer; Holger Martens; Andrea Fleig; Monika Schweigel
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

7.  Genetic analysis of SLC41A1 in Chinese Parkinson's disease patients.

Authors:  Ling Wang; Lan Cheng; Nan-Nan Li; Wen-Juan Yu; Xiao-Yi Sun; Rong Peng
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-08-26       Impact factor: 3.568

8.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Genetic variability at the PARK16 locus.

Authors:  Arianna Tucci; Mike A Nalls; Henry Houlden; Tamas Revesz; Andrew B Singleton; Nicholas W Wood; John Hardy; Coro Paisán-Ruiz
Journal:  Eur J Hum Genet       Date:  2010-08-04       Impact factor: 4.246

10.  Age at onset and Parkinson disease phenotype.

Authors:  Gennaro Pagano; Nicola Ferrara; David J Brooks; Nicola Pavese
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

View more
  6 in total

1.  SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.

Authors:  Morgan Sturgeon; Perry Wu; Robert Cornell
Journal:  J Neurol Neuromedicine       Date:  2016-12-30

2.  Aldehyde Dehydrogenase 2 (ALDH2) Glu504Lys Polymorphism Affects Collateral Circulation and Short-Term Prognosis of Acute Cerebral Infarction Patients.

Authors:  Yun Qu; Huilong Zhang; Haiyong Li; Limei Yu; Ying Sun; Yuguo Chen
Journal:  Med Sci Monit       Date:  2017-09-23

3.  Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.

Authors:  Jing Xie; Chien-Shan Cheng; Xiao Yan Zhu; Ye Hua Shen; Li Bin Song; Hao Chen; Zhen Chen; Lu Ming Liu; Zhi Qiang Meng
Journal:  Aging (Albany NY)       Date:  2019-05-08       Impact factor: 5.682

Review 4.  Impaired dopamine metabolism in Parkinson's disease pathogenesis.

Authors:  Anna Masato; Nicoletta Plotegher; Daniela Boassa; Luigi Bubacco
Journal:  Mol Neurodegener       Date:  2019-08-20       Impact factor: 14.195

5.  Alzheimer's Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak Study.

Authors:  Michal Cibulka; Maria Brodnanova; Marian Grendar; Jan Necpal; Jan Benetin; Vladimir Han; Egon Kurca; Vladimir Nosal; Matej Skorvanek; Branislav Vesely; Andrea Stanclova; Zora Lasabova; Zuzana Pös; Tomas Szemes; Stanislav Stuchlik; Milan Grofik; Martin Kolisek
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

6.  SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson's Disease and Healthy Controls: Statistics and Machine-Learning Evidence.

Authors:  Michal Cibulka; Maria Brodnanova; Marian Grendar; Milan Grofik; Egon Kurca; Ivana Pilchova; Oto Osina; Zuzana Tatarkova; Dusan Dobrota; Martin Kolisek
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.